Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4732)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2023 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang YQ, Wen ZY, Liu XY, Ma ZH, Liu YE, Cao XY, Hou L, Xie H. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(2): 129-150 [PMID: PMC10011906 DOI: 10.4254/wjh.v15.i2.129] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v15/i2/129.htm |
| Number | Citing Articles |
| 1 |
Yiquan Li, Pengpeng Xiao, Yu Sun, Yaru Li, Haifeng Zhao, Jialing Sun, Xue Wang, Xiaohong Han, Ningyi Jin, Xiao Li, Yongli Bao. Deapioplatycodin D promotes cell senescence induced by P21 through the mediation of incomplete mitophagy via BNIP3L. Biomedicine & Pharmacotherapy 2024; 178: 117215 doi: 10.1016/j.biopha.2024.117215
|
| 2 |
Mingyang Du, Yonggang Qu, Lingshan Qin, Jiahe Zheng, Wei Sun. The cell death‐related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18168
|
| 3 |
Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto. Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma. Annals of Surgical Oncology 2025; 32(2): 1073 doi: 10.1245/s10434-024-16363-w
|
| 4 |
Xuefeng Gu, Yanyan Wei, Duo Shen, Yuan Mao. Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12816-3
|
| 5 |
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Hui-Chen Lin, Yi-Chia Huang. Vascular endothelial growth factor is associated with hepatocellular carcinoma recurrence, independent of folate and glutathione-related antioxidant enzymes: A follow-up study. Nutrition Research 2024; 128: 70 doi: 10.1016/j.nutres.2024.06.010
|
| 6 |
Junyu Wu, Guoyi Tang, Chien-Shan Cheng, Ranna Yeerken, Yau-Tuen Chan, Zhiwen Fu, Yi-Chao Zheng, Yibin Feng, Ning Wang. Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02136-2
|
| 7 |
Xuefeng Gu, Yanyan Wei, Mao Lu, Duo Shen, Xin Wu, Jin Huang. Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial–Mesenchymal Transition. ACS Omega 2024; 9(50): 49986 doi: 10.1021/acsomega.4c09411
|
| 8 |
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1955 doi: 10.2147/JHC.S291553
|
| 9 |
Chunhua Rui, Longhuan Piao, Peng Wang. A commentary on ‘Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study’. International Journal of Surgery 2025; 111(1): 1648 doi: 10.1097/JS9.0000000000001223
|
| 10 |
Xiaoan Qi, Liang Liu. The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features. Clinics and Research in Hepatology and Gastroenterology 2024; 48(2): 102273 doi: 10.1016/j.clinre.2023.102273
|
| 11 |
Takashi Ishida, Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Joji Kitayama, Naohiro Sata. Preoperative Bone Loss Predicts Decreased Survival Associated with Microvascular Invasion after Resection of Hepatocellular Carcinoma. Cancers 2024; 16(11): 2087 doi: 10.3390/cancers16112087
|
| 12 |
Fereshteh Rahdan, Alihossein Saberi, Neda Saraygord-Afshari, Morteza Hadizadeh, Tahura Fayeghi, Elham Ghanbari, Hassan Dianat-Moghadam, Effat Alizadeh. Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights. Heliyon 2024; 10(20): e39489 doi: 10.1016/j.heliyon.2024.e39489
|